No Data
US Stock MarketDetailed Quotes
CVRX CVRx Inc
Watchlist
21.920
+1.450+7.08% Close 12/01 16:00 ET
22.200High20.290Low173.00KVolume
20.290Open20.470Pre Close3.70MTurnover1.58%Turnover RatioLossP/E (TTM)456.28MMarket Cap22.20052wk HighLossP/E (Static)20.82MShares6.57052wk Low5.51P/B240.70MFloat Cap29.000Historical High--Dividend TTM10.98MShs Float4.600Historical Low--Div YieldTTM9.33%Amplitude21.370Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About CVRx Inc Company
CVRx, Inc. engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It operates through the United States, Germany, and Other Countries geographical segments. The company was founded by Robert S. Kieval and Tyler P. Lipschultz in August 2001 and is headquartered in Minneapolis, MN.
News
Craig-Hallum Releases a Buy Rating on CVRx (CVRX)
Craig Hallum Adjusts CVRx Price Target to $24 From $22, Maintains Buy Rating
CVRx (CVRX) has an average Buy rating and price target range of $17 to $24, according to analysts polled by Capital IQ.
CVRx to Present at the 35th Annual Piper Sandler Healthcare Conference
MINNEAPOLIS, Nov. 15, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuro